FOCUS health, turnover climbed by 1.3% to €86 M, with the rise in pharmaceuticals and healthcare compensating for reduced functional foods sales. Sales of the process chemicals unit were unchanged at €64 M. Cognis Oleochemicals, the 50:50 joint venture between Cognis and Golden Hope, saw its 1Q sales rise to €150 M, up by 8.2% from €139 M in 1Q 2006. On an organic basis, growth was €15 M, or 11.1%. All regions contributed to this sales development. ICIS Chemical Business, 4 Jun 2007, (Website: http://icischemicalbusiness.com) & press release from: Cognis Deutschland GmbH & Co KG, Germany. Tel: +49 2173 4995 464. Website: http://www.cognis.com (30 May 2007)
Novozymes 1Q 2007: sales of enzymes For its 1Q 2007, Novozymes A/S has reported sales of DKR 1931 M (DKR 1633 M for its 1Q 2006), of which enzymes contributed DKR 1727 M (DKR 1516 M). Detergent enzymes accounted for sales of DKR 572 M (DKR 505 M in 1Q 2006), technical enzymes DKR 542 M (DKR 453 M), food enzymes DKR 434 M (DKR 387 M) and feed enzymes DKR 179 M (DKR 171 M). Sales of microorganisms reached DKR 84 M in 1Q 2007 (DKR 94 M) and biopharmaceuticals DKR 120 M (DKR 23 M). Novozymes reported that negative exchange rate movements, particularly in the dollar, reduced growth in enzyme sales by 5 percentage points, though sales rose by 19% in local currencies. Sales of enzymes in 1Q 2007 were significantly higher than expected at the beginning of the year. Sales of detergent enzymes in the period rose by 13% in DKR and 16% in local currencies compared with 1Q 2006. This development was mainly due to increased sales of detergent enzymes to Asia and Latin America [Focus on Surfactants, Jul 2007], and a higher market share in Europe. Increased penetration of new products also had a positive impact on growth. Some of the growth is also considered to relate to timing shifts in detergent manufacturers’ purchasing. As a result, Novozymes is increasing the outlook for 2007 sales of both detergent and technical enzymes. The company launched three new products in 1Q 2007: Mannaway, a detergent enzyme, which has now been launched globally [ibid, Mar 2007]; Viscoferm, an AUGUST 2007
ON
S U R FAC TA N T S
enzyme for the alcohol industry; and HyaCare, an optimized hyaluronic acid for the eyecare medical device market. Around 26% of revenue in 1Q 2007 derived from products launched in the past five years. Novozymes Group Financial Statement 1Q 2007, 25 Apr 2007, 3,5,15 (Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark. Tel: +45 8824 9999. Fax: +45 8824 9998. Website: http://www.novozymes.com)
COMPANY NEWS Procter & Gamble increases production in Russia Procter & Gamble has three plants in Russia: P&G Novomoskovsk (household chemicals, Moscow region), Kapella (cosmetics, Nizhegorodsk region) and Peterburg Product Inter. In 2006 P&G’s sales in Russia were about $1.3 bn and are expected to rise by 20-30%/y over the next few years. During the last 15 years, P&G has invested around $270 M in Russia. P&G is planning to invest more than $100 M during the next three years to develop its production facilities in Russia. The Russian market for perfumes and cosmetics is $8 bn/y and household chemicals $5 bn/y. P&G accounts for 40% of the household chemicals market in that country. RBK Daily, 6 Jun 2007, (101), 8 (in Russian)
Shaowu Anshengqi Chemical starts production During 2007, four fluorine chemical facilities have been started up in the Shaowu Jintang Fine Chemical Industry Park, Fujian province, China. They include Shaowu Anshengqi Chemical Co Ltd’s plant which produces fluorine surfactants. China Chemical Reporter, 26 May 2007, 18 (15), 14
Clariant announces further price increases Clariant has announced further price increases affecting various product segments of the Textile, Leather & Paper Chemicals, Pigments & Additives as well as Functional Chemicals Divisions with immediate
effect. The continued high level of crude oil prices and energy costs as well as reduced supply for key raw materials due to the closing of several production plants in China to decrease environmental impact is causing an ongoing increase in raw material prices, the company says. Among others, the prices of Dyes, Pigments, Optical Brighteners, Polymer Dispersions, Leather Chemicals and Ethoxylates are being increased by between 5% and 30%. Clariant’s Functional Chemicals Division recently announced price adjustments to address both recent and announced raw material cost increases especially for products containing ethylene, ethylene oxide as well as fatty alcohols and fatty acids. Press release from: Clariant, Rothausstrasse 61, CH4132 Muttenz, Switzerland. Tel: +41 61 469 6745. Fax: +41 61 469 6767. Website: http://www.clariant.com (2 Jul 2007)
Dabur lathers up soaps segment with new launch strategy The Rup 22.34 bn FMCG major Dabur India Ltd plans to focus on its soaps portfolio. The company, which offers the soap brand Vatika in two variants, will introduce more soaps based on the ayurvedic heritage as a health platform under the Dabur brand by 2Q 2007-2008. Vatika, which has variants Honey & Saffron and Sandal & Saffron, will be extended to another variant, Orange Peel & Saffron soap. At present the Vatika brand of soaps is worth Rup 200 M in the total Indian soap market of Rup 45 bn. Business Line, 13 Jun 2007, 14 (163), 5
Corum appoints four North American distributors MG Force, Tempo Canada Inc, Charkit Chemical Corp and Ross Organic Specialty Sales Inc have been designated by Corum Corp as its new distributors in the North American region. Corum, based in Taipei, Taiwan, produces an extensive line of speciality ingredients for personal care products including mild glutamate surfactants and sugar esters. HAPPI, Household & Personal Products Industry, May 2007, 44 (5), 158-159
7